Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2021

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table summarizes the disaggregation of revenue by nature:

	Three Months Ended June 30,				Six Months Ended June 30,
Dollars in Millions	2021		2020		2021		2020
Net product sales	$	11,405	$	9,817	$	22,203	$	20,358
Alliance revenues	159		163		301		268
Other revenues	139		149		272		284
Total Revenues	$	11,703	$	10,129	$	22,776	$	20,910

Revenue Recognition Gross-To-Net Adjustments [Table Text Block]

The following table summarizes GTN adjustments:

	Three Months Ended June 30,				Six Months Ended June 30,
Dollars in Millions	2021		2020		2021		2020
Gross product sales	$	16,782	$	13,788	$	32,341	$	28,474
GTN adjustments(a)
Charge-backs and cash discounts	(1,720)		(1,292)		(3,306)		(2,632)
Medicaid and Medicare rebates	(2,139)		(1,482)		(3,857)		(2,980)
Other rebates, returns, discounts and adjustments	(1,518)		(1,197)		(2,975)		(2,504)
Total GTN adjustments	(5,377)		(3,971)		(10,138)		(8,116)
Net product sales	$	11,405	$	9,817	$	22,203	$	20,358

(a)    Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $85 million and $302 million for the three and six months ended June 30, 2021, and $44 million and $116 million for the three and six months ended June 30, 2020, respectively.

Revenue from External Customers by Products and Services [Table Text Block]

The following table summarizes the disaggregation of revenue by product and region:

	Three Months Ended June 30,				Six Months Ended June 30,
Dollars in Millions	2021		2020		2021		2020
Prioritized Brands
Revlimid	$	3,202	$	2,884	$	6,146	$	5,799
Eliquis	2,792		2,163		5,678		4,804
Opdivo	1,910		1,653		3,630		3,419
Orencia	814		750		1,572		1,464
Pomalyst/Imnovid	854		745		1,627		1,458
Sprycel	541		511		1,011		1,032
Yervoy	510		369		966		765
Abraxane	296		308		610		608
Empliciti	86		97		171		194
Reblozyl	128		55		240		63
Inrebic	16		15		32		27
Onureg	12		—		27		—
Zeposia	28		1		46		1
Breyanzi	17		—		17		—
Abecma	24		—		24		—
Established Brands
Vidaza	45		126		99		284
Baraclude	109		121		222		243
Other Brands	319		331		658		749
Total Revenues	$	11,703	$	10,129	$	22,776	$	20,910
United States	$	7,388	$	6,487	$	14,398	$	13,253
Europe	2,689		2,136		5,242		4,703
Rest of the World	1,435		1,334		2,781		2,669
Other(a)	191		172		355		285
Total Revenues	$	11,703	$	10,129	$	22,776	$	20,910

(a)    Other revenues include royalties and alliance-related revenues for products not sold by BMS’s regional commercial organizations.